IHC analysis of archived paraffin-embedded PCa specimens (n = 9) revealed significantly higher ELOVL2 expression in tumor tissues, particularly in enzalutamide-resistant cases, whereas adjacent non-tumorous tissues showed minimal expression (Supplementary Figure S2). The gene discussed is ELOVL2; the disease is neoplasm.